PSP
INFI

Pacific Sage Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Pacific Sage Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,000
Closed -$3.2K – 97
2023
Q1 		$3.2K Buy
20,000
+2,500
+14% +$1.11K ﹤0.01% 88
2022
Q4 		$9.7K Buy
+17,500
New +$14.9K ﹤0.01% 87

Other funds holding INFI

BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pacific Sage Partners's INFI Position: Q2 2023 in Review

Pacific Sage Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 20,000 shares — an estimated $3.2K sold.

Pacific Sage Partners first reported a position in INFI in Q4 2022 and held it in 2 quarters. The position peaked at $9.7K in Q4 2022. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.

  • Pacific Sage Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Pacific Sage Partners sold 20,000 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.2K.
  • Pacific Sage Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2022 and held it in 2 quarters.
  • Pacific Sage Partners's Infinity Pharmaceuticals, Inc. position peaked at $9.7K in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.

Based on Pacific Sage Partners's 13F filing for Q2 2023, filed 20 Jul 2023.